Gilead Sciences Stock Forecast & Price Target
Gilead Sciences Price Target 2026
The Quantum Forecast sees a price target of $173.79 (+2.9%) for Gilead Sciences in about one month (by Dec 10, 2026).
Quantum Forecast price targets by time frame, calculated from the current price of $168.97. Click to see the forecast in the chart.
Gilead Sciences Forecast for Today and Tomorrow
In the short term, the Quantum Forecast sees Gilead Sciences at $169.07 (+0.06%) today around 9:45 AM ET and at $168.28 (−0.41%) today around 2:30 PM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart
Gilead Sciences Stock 2026: Price Performance
Gilead Sciences stock has gained 37.6% since the start of 2026 and currently trades at $168.97 (as of Nov 11, 2026). Over the same period the Nasdaq 100 is up 11.9%, putting the stock 25.7 percentage points ahead of the index. Over the past 52 weeks the price ranged between $116.47 and $176.41; it is currently 4.2% below its high of Nov 5, 2026.
Gilead Sciences Forecast 2027
Over a horizon of roughly 10 months (until about Sep 2027), the Quantum Forecast sees a price target of $147.85 for Gilead Sciences – −12.5% from today. The range band runs from $100.70 – $195.00: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart
Community Forecast for Gilead Sciences
18 user forecasts (all years): 94% long, 6% short.
Make your own forecastAbout Gilead Sciences
Gilead Sciences, founded in 1987 and based in Foster City, California, develops and sells prescription medicines for viral diseases, cancer and inflammatory conditions. HIV is the company's most important franchise, led by the treatment Biktarvy and the prevention products Descovy and the twice-yearly injection Yeztugo (lenacapavir). Gilead also markets hepatitis B and C drugs such as Vemlidy and Epclusa, the COVID-19 antiviral Veklury, the breast cancer drug Trodelvy and cell therapies Yescarta and Tecartus through its Kite unit.
The United States is the largest market, followed by Europe. The company's HIV portfolio produces steady cash flow, while long-acting treatment and prevention are seen as the next growth stage. Investors watch patent timelines, US drug pricing policy, payer negotiations and the progress of the oncology pipeline. Gilead has a long history of dividend payments. The stock trades on the Nasdaq under the ticker GILD and is included in both the Nasdaq-100 and the S&P 500.
The current price of Gilead Sciences stock is $168.97 (−1.52% vs. the previous close). In today's trading the high was $169.50 and the low $168.32.
How the Quantum Forecast works
Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.
Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.
Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.
Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.
The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence
Frequently Asked Questions about Gilead Sciences Stock
What is the Gilead Sciences stock forecast?
The Quantum Forecast expects Gilead Sciences to reach $173.79 in about one month (by Dec 10, 2026), a change of +2.9% from the current price of $168.97. Over roughly 10 months (by Sep 2027) the price target is $147.85 (−12.5%).
What is the Gilead Sciences stock price target?
Quantum Forecast price targets by time frame: 1 month $173.79 (+2.9%), 2 months $162.16 (−4.0%), 6 months $157.52 (−6.8%), 10 months $147.85 (−12.5%). The range band shows the typical fluctuation around these targets.
Will Gilead Sciences stock go up or down?
In the short term the Quantum Forecast points up (+2.9% over one month). The community is 94% long (18 forecasts, all years). No forecast is certain – it is based on historical prices and statistical analysis.
How is the Quantum Forecast computed?
Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.
Can I make my own forecast for Gilead Sciences?
Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.